Skip to content

Signaling Pathway Activation After Exercise in Patients With Chronic Obstructive Pulmonary Disease

Signaling Pathway Activation in the Quadriceps of Patients With COPD After an Acute Bout of Resistance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01561625
Acronym
SIM
Enrollment
21
Registered
2012-03-23
Start date
2009-10-31
Completion date
2013-04-30
Last updated
2013-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD, exercise training

Brief summary

Muscle weakness and atrophy are important consequences of chronic obstructive pulmonary disease (COPD). Although resistance exercises increase strength and muscle mass in patients with COPD, the response to training appears to be suboptimal in these individuals. A dysregulation in the signaling pathways involved in the regulation of muscle mass could play an important role in this phenomenon. Hypothesis: Proteins involved in muscle mass regulation will be less activated in the quadriceps of patients with COPD following the acute bout of resistance training exercise compared to healthy age-matched controls.

Detailed description

Our objective is to investigate the impact of an acute bout of resistance training on key signaling pathways involved in the regulation of muscle mass in moderate to severe COPD (FEV1 under 60% of predicted). Key proteins of signaling intramuscular pathways involved in protein synthesis and degradation will be measured before after 72 contractions of the quadriceps. The exercise protocol was designed to match the actual exercise prescription model use in the context of pulmonary rehabilitation. A squat, leg press and leg extension will be done at 80% of max with one minute rest between sets. A biopsy of the quadriceps will be done before and after exercise in order to measure phosphorylated kinases, total protein content and mRNA expressions. All our patients will undergo a thorough baseline assessment in pulmonary capacity, muscle force and body composition.

Interventions

OTHERexercise

resistance training exercise, 1 session, 3 exercises, 80% of max

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
Laval University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
50 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Male * COPD with an FEV1 of under 60% of predicted * non-smoker * Between 50 and 75 years old

Exclusion criteria

* All inflammatory disease (HIV, Cancer, renal and cardiac deficiency) * Hormonal dysregulation * Inferior limb pathology * Neuromuscular pathology * History of tabacco or alcool abuse * Oxygen dependent * Recent exacerbation (2 months) of the symptoms of COPD

Design outcomes

Primary

MeasureTime frameDescription
Post-exercise signaling proteins phosphorylation level in the quadriceps of COPD patients and age-matched healthy controls2 hours post-exercisePhosphorylation status of key proteins (Akt, p70, mTOR, p38, JNK, ERK) will be lesser modulated in the quadriceps of patients with COPD compare to healthy controls. The phosphorylated as well as the total protein levels will be measured by western blot. The data will be presented as arbitrary units and compared with values obtained in healthy age-matched healthy controls.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026